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Introduction
The syndrome of progressive, ascending or
descending  hemiplegia,  with  no  significant
sensory  impairment  was  first  describes  by
Mills in 1900,
1which several cases were report-
ed later. However, after diagnostic tests and
image improvements, the number of reports
has shortened.
2 A possible explanation for this
shortage is the identification of other diseases
that  could  mimic  the  clinical  picture.
Currently,  the  syndrome  has  an  uncertain
nosological  status,  since  it  was  described
based  on  clinical  examination  only.  We  can
find  this  clinical  presentation  (Mills  syn-
drome) in cases of amyotrophic lateral sclero-
sis (ALS), predominant upper motor neuron
amyotrophic lateral sclerosis (UMN-ALS) and
primary  lateral  sclerosis  (PLS),  besides  its
symptomatic (secondary) forms. We describe a
case (initial presentation and one year follow-
up) of progressive ascending hemiplegia with
clinical isolated upper neuron signs and nor-
mal sensory examination, discussing its noso-
logical status, electromyographic findings, dif-
ferential diagnosis and prognosis.       
Case Report 
A man, 55-year-old engineer, was evaluated
in the neurology unit presenting a 2-years his-
tory of progressive weakness initially on left
lower limb, ascending after 6 months to the left
upper limb. He had difficulties to walk and con-
stantly fell down. He described occasional feel-
ing of muscle twitches and frequent cramps in
the left leg. He denied any abnormal sensation
or altered perception. He didn’t have abnormal
bladder and bowel function or difficulties to
swallow.
Neurological examination showed left hemi-
paresis
3 with hyperreflexia, spastic hypertonia
4
and Babinski sign. Although, on the right side,
just the patellar jerk was increased, it was less
intensely then the left one, with no signs of
fasciculations. 
Screen for HIV, HTLV I-II, VDRL, FTA-ABS
were negative, as well as serum rheumatolog-
ic  tests  including  antiphospholipid  antibody,
PTH,  calcium  and  protein  electrophoresis.
Analysis of spinal fluid showed no abnormali-
ties.
Needle electroneuromyography showed evi-
dence of chronic denervation in the left first
dorsal interosseous and left and right gastroc-
nemius  muscles.  Nerve  conduction  studies
were  normal.  Complementary  investigation
with  brain  MRI  showed  subtle  hypersignal
lesion in the right corona radiata, without con-
trast  enhancement,  that  is  unspecific  and
could not explain the neurologic syndrome, a
mild dilatation of the left lateral ventricle and
diffuse  bilateral  hyperintensities  along  the
pyramidal tract extending from corona radiate
to brainstein (Figure A and B). Tractography
did not showed abnormalities in the pyramidal
fibers. MRI of the cervical, thoracic and lumbar
spinal  MRI  was  normal.  The  patient  was
already using riluzole 100 mg per day and lithi-
um  carbonate  600  mg  per  day  (introduced
before our evaluation by other medical serv-
ice). We discussed the possibility of a motor
neuron disease with the patient and by con-
sensus; we resolved to keep on the medica-
tions despite the lack of certitude about the
diagnosis and the efficacy of lithium therapy.
5
At the follow-up visit, one year after initial
evaluation,  neurologic  examination  showed
the same pattern of hemiparesis with a slight
worst in the pelvic girdle muscles on the right
side and in spasticity. He did not have any sign
of atrophy or fasciculation, yet he still com-
plained sensation of muscles twitches. He was
still able to walk with help of a calf, and denied
any bulbar or cognitive symptom. Needle elec-
troneuromyography  showed  normal  sensory
and  motor  nerve  conduction  velocities  and
signs of active denervation in distal muscles of
the four extremities at needle electromyogra-
phy. These signs of denervation were repre-
sented for positive sharp waves 1 or 2+/4+ or
fibrillation potentials 1 or 2+/4+ and rare fas-
ciculation potentials with reduced recruitment
of  large-amplitude  long-duration  motor  unit
action potentials in the affected muscles; these
muscles  were  the  right  and  left  first  dorsal
interosseous of the hands and right and left
first dorsal interosseous of the foot. This EMG
finding was suggesting active denervation but
did  not  fulfill  the  EMG  parameters  of  El
Escorial  Criteria,  which  are  the  needed  evi-
dences of lower motor neuron degeneration in
two muscles supplied by different nerve roots
or nerves in a limb. 
We discussed the diagnosis with the patient
and offered the possibility to remain with rilu-
zol and lithium for possible ALS with atypical
presentation. The patient remained under fol-
low-up  in  our  outpatients’  clinic  at  regular
intervals. Another EMG study should be per-
formed later in this patient to pursue more evi-
dence of denervation. 
Discussion
This  patient  presented  a  progressive
ascending motor neuron disease, with a clear
asymmetric  involvement,  with  slow  paresis
progression.  Although  his  symptoms  were
compatible with fasciculations (muscle twitch-
es sensation), only upper motor neuron find-
ings  were  evident  on  clinical  examination.
MRI  was  nondiagnostic.  Needle  electroneu-
romyography  showed  mild  signs  of  denerva-
tion on muscles of cervical segment on left and
right  side  and  lumbosacral  segment  in  both
lowers limbs.  Other possible causes such as
metabolic,  infectious,  immunologic,  and
hereditary were excluded by history and com-
plementary studies. A PET scan was consid-
ered but unfortunately, the exam was not avail-
able in our service. What should then be the
diagnosis of this patient? 
According to the current proposed diagnos-
tic criteria, this patient has neither ALS nor
PLS.
6-8
ALS is a neurodegenerative motor neuron
disease,  in  which  the  current  criterion
requires evidence of both upper motor neuron
and lower motor neuron (LMN) degeneration.
This should be demonstrated by clinical, elec-
trophysiological, or neuropathological exami-
nations. According to the disease’s pattern, the
symptoms  ought  necessarily  to  spread  and
progress within a segment and from one seg-
ment throughout others (cranial, cervical, tho-
racic and lumbosacral) in order to attend ALS
criteria.
6 The  El  Escorial  electrophysiological
criterion calls for signs of ongoing/acute den-
ervation  (fibrillation  potentials  and  positive
sharp  waves)  and  chronic  denervation/rein-
nervation (large motor units, reduced interfer-
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[page 54] [Neurology International 2009; 1:e15]ence  patters  with  firing  rates  higher  than
10Hz, and unstable motor units), in at least
one muscle innervated by cranial, and thoracic
segments. Association of at least two muscles
innervated by different peripheral nerves and
roots are also required in the cervical and lum-
bosacral segments.
6,9,10
Primary  lateral  sclerosis  is  an  idiopathic
neurodegenerative  disorder  of  UMN,  with
slowly  progressive  spastic  paresis,  usually
beginning in the lower limbs and evolving to a
spastic  tetraparesis,  with  marked  pyramidal
signs, and bulbar involvement.
11 The two pro-
posed criteria
7,8 for PLS require the absence of
LMN signs on clinical, and electrophysiological
examination during the first three years of dis-
ease. Other authors prefer four years for a bet-
ter  diagnostic  specificity.
12 Moreover,  some
authors doubt the existence of isolated UMN
syndrome, arguing that it is one end of a con-
tinuous spectrum of motor neuron diseases.
13
Regardless this discussion, proposed diagnos-
tic criterion for PLS excludes any lower motor
neuron involvement on EMG, even with asymp-
tomatic.
Predominant upper motor neuron ALS
12 is
evidenced  by  degeneration  mainly  in  UMN,
with clinical signs and disability due to corti-
cospinal  or  corticobulbar  damage.  However,
only minor clinical and EMG involvement of
LMN, which are not severe enough to meet
ALS diagnostic criteria, may be present. UMN-
ALS is different from classical ALS in the pro-
gression  rate  and  time  of  survival,  which
enables a better long-term prognosis. 
In 1900, Mills
1,14 described eight cases of a
very  slow  progressive  form  of  hemiplegia
beginning usually in the extremity of a lower
limb, then ascending to the homolateral upper
limb and believed it was a new motor neuron
disease. Some cases were reported later, but
fewer  of  them  after  advances  in  diagnostic
methods.
15-18 In  those  cases  pyramidal  signs
were always seen on the side of hemiplegia
and often bilaterally, and a moderate amyotro-
phy without fasciculations can be commonly
seen. The symptoms are gradually progressive,
and the progression is frequently more ascend-
ing than descending, and the palsy can also
involve  the  facial  muscles.  Sensory  distur-
bances  are  generally  absent.  There  was  no
family history of the syndrome in any of the
cases. Gastaut et al.
14 published in 1994 two
further cases, similar to the ones described by
Mills. The postmortem findings in one of Mills’
original  cases  even  described  lesions  at  the
level of the brainstem and spinal cord, sparing
the motor cortex.
19The clinical picture present-
ed  by  our  patient  is  very  similar  to  that
described previously. 
A study conducted by Turner et al.
20 used an
11C-(R)-PK11195 positron emission tomogra-
phy (PET) to explore and delineate in vivo the
cortical  lesion  in  clinically  isolated  cases  of
upper motor neuron syndrome. Two patients
had  clinical  features  similar  to  the  cases
described by Mills, and demonstrated marked
increases  in  binding  in  the  superior  frontal
region  (supplementary  motor  region)  con-
tralateral to the affected limbs.
What is called Mills’ syndrome could be all
the variant of motor neuron diseases spectrum
(ALS, PLS or UMN-ALS) in a hemiplegic, or
asymmetrical pattern of involvement.  A syn-
drome is a collective of symptoms and signs
that  could  have  many  etiologies.  Therefore,
Mills syndrome should be conceptualized as a
motor neuron syndrome with a hemiplegic or
markedly asymmetrical pattern of involvement,
not like a different disease. This vision is rein-
forced by recent reports
2,20-23 that several dis-
eases  could  cause  this  patters,  including
Waldenström  macroglobulinemia,  antiphos-
pholipid syndrome, progressive multiple scle-
rosis, myelitis of unknown origin and multiple
infarctions.  Moreover,  the  paucity  of  neu-
ropathological  data  from  autopsies,  and  the
lack of distinction between these motor neu-
ron diseases call in to question the concept of
Mills syndrome as a new nosological entity.
With this study, we propose that the clinical
syndrome  of  progressive  ascending  or
descending  hemiplegia,  or  even  those  with
bilateral but marked asymmetry, without sig-
nificant sensory impairment, should be called
Mills’  syndrome,  considering  that  there  are
several diseases that may cause it.  
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